Strumento inattivo

Altre lingue AKOUOS

Azioni

AKUS

US00973J1016

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Akouos, Inc. Announces Positive Initial Clinical Results from the Phase 1/2 AK-OTOF-101 Study	23/01
AKOUOS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	01/12/22
Akouos, Inc. Announces Executive and Board Changes	01/12/22
Eli Lilly : a finalisé l'acquisition d'Akouos	01/12/22
Lilly Wraps Up Acquisition of Akouos	01/12/22
Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Composite Index	01/12/22
Eli Lilly and Company completed the acquisition of Akouos, Inc. from a group of shareholders.	01/12/22
Eli Lilly : vers l'acquisition de 81.1% des actions d'Akouos	30/11/22
Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing	30/11/22
Lilly and Akouos Announce Expiration of Akouos Tender Offer	30/11/22
Akouos, Inc.(NasdaqGS:AKUS) dropped from S&P TMI Index	30/11/22
Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Biotechnology Index	29/11/22
Akouos Q3 Loss Narrows	14/11/22
AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22
Akouos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
AKOUOS, INC. : Results of Operations and Financial Condition (form 8-K)	14/11/22
Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights	14/11/22
North American Morning Briefing : Fed Hopes, China -2-	11/11/22
AKOUOS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS	19/10/22
Health Care Up Amid Earnings, Deals -- Health Care Roundup	18/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue AKOUOS

Azioni

AKUS

US00973J1016

Altre lingue

Filtri